JUNIPER PHARMACEUTICALS INC (JNP) financial statements (2020 and earlier)

Company profile

Business Address 33 ARCH STREET
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments212114172129
Cash and cash equivalents212114172113
Short-term investments     15
Receivables8886116
Inventory, net of allowances, customer advances and progress billings664333
Inventory664333
Prepaid expense and other current assets1
Other undisclosed current assets0010(2)(2)
Total current assets:363526263236
Noncurrent Assets
Property, plant and equipment15131313131
Intangible assets, net (including goodwill)109121314
Goodwill98101111 
Intangible assets, net (excluding goodwill)11223 
Other noncurrent assets00000
Deferred tax assets, net    1 
Other undisclosed noncurrent assets     0
Total noncurrent assets:25232526281
TOTAL ASSETS:615851526037
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities985554
Accounts payable442332
Accrued liabilities333222
Employee-related liabilities22 1  
Debt10000 
Restructuring reserve0   
Due to related parties     0
Deferred revenue and credits664110
Other undisclosed current liabilities01 (1) (0)
Total current liabilities:161510664
Noncurrent Liabilities
Long-term debt and lease obligation32334 
Long-term debt, excluding current maturities32334 
Liabilities, other than long-term debt001220
Deferred revenue and credits 01220
Other liabilities0     
Other undisclosed noncurrent liabilities    01
Total noncurrent liabilities:324561
Total liabilities:20171411135
Temporary equity, carrying amount 11   
Stockholders' equity
Stockholders' equity attributable to parent, including:424037414731
Preferred stock    00
Treasury stock, value(9)(9)(9)(9) (0)
Additional paid in capital292291289288287279
Accumulated other comprehensive income (loss)(3)(5)(1)(0)10
Accumulated deficit(239)(237)(243)(238)(242)(248)
Other undisclosed stockholders' equity attributable to parent000001
Other undisclosed stockholders' equity   1  
Total stockholders' equity:424037414731
Other undisclosed liabilities and equity    11
TOTAL LIABILITIES AND EQUITY:615851526037

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
505538322926
Cost of revenue(29)(24)(21)(18)(13)(13)
Cost of goods and services sold(29)(24)(21)(18)(13)(1)
Gross profit:213017151613
Operating expenses(25)(25)(19)(11)(10)(10)
Operating income (loss):(4)5(2)463
Nonoperating income (expense)2101(0)7
Foreign currency transaction loss, before tax(1)(0)(0)(0)(0) 
Other nonoperating income (expense)2100(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes    1 
Income (loss) from continuing operations before income taxes:(2)6(1)4710
Income tax expense (benefit)0(0)(0)(1)(0)(0)
Net income (loss) attributable to parent:(2)6(1)3710
Preferred stock dividends and other adjustments0(0)(0)(0)(0)(0)
Net income (loss) available to common stockholders, basic:(2)6(2)3710
Dilutive securities, effect on basic earnings per share   0(1)7
Other undisclosed net income (loss) available to common stockholders, diluted 0 (1)0(14)
Net income (loss) available to common stockholders, diluted:(2)6(2)363

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(2)6(1)3710
Other comprehensive income (loss)   (1)1 
Comprehensive income (loss):(2)6(1)2810
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(4)(1) (0)0
Comprehensive income (loss), net of tax, attributable to parent:(0)2(3)2810

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: